Skip to main content

Advertisement

SpringerLink
Log in

99mTc-M-TRODAT is not superior to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1. A

References

  1. Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, Van Royen EA. Practical benefit of123I-FP-beta-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med 1997; 24:68–71.

    Google Scholar 

  2. Walker Z, Costa DC, Ince P, Mc Keith IG, Katona CL. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 1999; 354:646–647.

    Google Scholar 

  3. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996; 23:1527–1530.

    Google Scholar 

  4. Mozley LH, Gur RC, Mozley PD, Gur RE. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 2001; 158:1492–1499.

    Google Scholar 

  5. Kushner SA, McElgin WT, Kung MP, Mozley PD, Plössl K, Meegalla SK, Mu M, Dresel S, Vessotskie JM, Lexow N, Kung HF. Kinetic modelling of99mTc TRODAT-1: a dopamine transporter imaging agent. J Nucl Med 1999; 40:150–158.

    Google Scholar 

  6. Plössl K, Kung M-P, Meegalla SK, Dresel S, Kushner SA, Mu M, Huang X-F, Mozley PD, Kung HF. [Tc-99m]M-TRODAT: an improved dopamine transporter imaging agent. J Nucl Med 1998; 39:6P.

    Google Scholar 

  7. Meegalla SK, Plössl K, Kung M-P, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem 1997; 40:9–17.

    Google Scholar 

  8. Cleynhens B, Vanbilloen H, Bormans G, de Groot T, Verbruggen A. Synthesis and isolation of the diastereomers of 4-tolyl-, 4-ethylphenyl- and 2,4-dimethylphenyl derivatives of99mTc-TRODAT-1. J Labelled Compd Radiopharm 2001; 44:S529–S531.

    Google Scholar 

Download references

Acknowledgements

The authors thank Dr. H. Kung for the helpful discussions and for kindly agreeing to the performance of this study.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Laboratory of Radiopharmaceutical Chemistry, University Hospital Gasthuisberg, K.U. Leuven, Herestraat 49, 3000, Leuven, Belgium

    A. Maes, H. Vanbilloen, B. Cleynhens, L. Mortelmans, G. Bormans & A. Verbruggen

Authors
  1. A. Maes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Vanbilloen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Cleynhens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Mortelmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Bormans
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Verbruggen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Verbruggen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maes, A., Vanbilloen, H., Cleynhens, B. et al. 99mTc-M-TRODAT is not superior to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease. Eur J Nucl Med Mol Imaging 30, 796–797 (2003). https://doi.org/10.1007/s00259-003-1125-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1125-1

Keywords

Search

Navigation